Magnetic Resonance Imaging Is Cost ‐Effective for Hepatocellular Carcinoma Surveillance in High Risk Patients with Cirrhosis

ConclusionsSemiannual surveillance using MRI with liver ‐specific contrast may be more cost‐effective than US in patients with virus‐associated compensated cirrhosis at sufficiently high HCC risk despite the higher test cost of MRI.This article is protected by copyright. All rights reserved.

Source: Hepatology - October 26, 2018 Category: Internal Medicine Authors: Hye ‐Lin Kim, Jihyun An, Jae‐A Park, Seung‐Hoo Park, Young‐Suk Lim, Eui‐Kyung Lee Tags: Original Source Type: research